Pharmasource D2r Private Limited - Company Profile

It is a business services private limited company based in Chandigarh, Chandigarh, India, established in 2024.
2024 Chandigarh, Chandigarh, India Active
Last Updated:
Access Report
About Pharmasource D2r Private Limited

Pharmasource D2r Private Limited, a active private limited company, was established on 30 May 2024 in Chandigarh, Chandigarh, India. it holds CIN: U46497CH2024PTC045730. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹0.10 M.

Its leadership includes Karan Chopra (Director), Madhav Chopra (Director). Past directors included Yogendra Chopra. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at B-308, Elante Offices, Industrial And Business Park Phase 1, Chandigarh, Chandigarh, 160002.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U46497CH2024PTC045730

  • Registration Number

    045730

  • Incorporation Date

    30 May 2024

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Chandigarh

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 0.10 M
  • Company Age 1 Year 8 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Pharmasource D2r Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Pharmasource D2r Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Pharmasource D2r Private Limited?
Current Directors
Name Designation Appointment Date Status
Karan Chopra Director 30 May 2024 Current
Madhav Chopra Director 30 May 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Individual Subscriber - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Pharmasource D2R.

Enhance accessibility to Pharmasource D2R's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Pharmasource D2R revenue growth over time
Pharmasource D2R profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Pharmasource D2R?

Unlock access to Pharmasource D2R's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Pharmasource D2R?

Unlock and access historical data on people associated with Pharmasource D2R, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Pharmasource D2R, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmasource D2R's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Pharmasource D2R
Recent Activity within the Organization
  • Annual General Meeting

    The activity Pharmasource D2R Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Pharmasource D2R Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh. was recorded as a recent event.

  • Director Appointment

    The activity Karan Chopra was appointed as a Director was appointed as a Director on 30 May 2024 & has been associated with this company since 1 year 8 months . was completed.

  • Director Appointment

    Madhav Chopra was appointed as a Director was appointed as a Director on 30 May 2024 & has been associated with this company since 1 year 8 months . was recorded as a recent event.

  • Company Incorporation

    The activity Pharmasource D2R Private Limited was registered on 30 May 2024 with Roc Chandigarh & aged 1 year 8 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Pharmasource D2r Private Limited?

The CIN of Pharmasource D2r Private Limited is U46497CH2024PTC045730.

Where is Pharmasource D2r Private Limited headquartered?

Pharmasource D2r Private Limited is headquartered at B-308, Elante Offices, Industrial And Business Park Phase 1, Chandigarh, Chandigarh, 160002.

When was Pharmasource D2r Private Limited incorporated?

Pharmasource D2r Private Limited was incorporated on 30 May 2024.

Who are the current directors of Pharmasource D2r Private Limited?

The current directors of Pharmasource D2r Private Limited are

Is Pharmasource D2r Private Limited a listed company?

Pharmasource D2r Private Limited is unlisted.

What is the capital structure of Pharmasource D2r Private Limited?

The authorized capital of Pharmasource D2r Private Limited is ₹1.00 Cr, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available